Fisetin for better walking in peripheral artery disease
Treatments studied
Part of Heart & circulation clinical trials.
This study tests whether a supplement called fisetin can help reduce leg pain and improve walking ability in people with peripheral artery disease (PAD). If you have PAD and are 50 or older, you may be able to join and help see if fisetin can make walking easier.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 50 years old or older.
- You must have peripheral artery disease (PAD) – a condition that causes leg pain with walking due to blocked leg arteries.
- You must be able to walk at least 500 feet (about 1½ football fields) in 6 minutes, but not more than 1600 feet (about 5 football fields).
- You should not have had major surgery, a heart attack, or a leg artery procedure in the past 3 months.
- You should not be taking the supplement fisetin or have taken it in the past 3 months.
- You cannot have serious health issues like needing oxygen for lung disease, Parkinson's, cancer treatment in the last 2 years (unless early stage with good outlook), or a life expectancy less than 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a home-based exercise program is as effective as supervised exercise for improving walking ability in people with peripheral artery disease (PAD). You will be randomly assigned to one of two exercise groups, and you may be asked to drink beetroot juice as part of the study.
This study tests whether adding light therapy to a walking program helps people with peripheral artery disease (PAD) walk further and feel better. You'll receive either light therapy or a placebo light while doing a supervised exercise program.
This trial tests whether a drug called diroximel fumarate (Vumerity) can improve blood flow and walking ability in people with peripheral artery disease (PAD). It compares people with PAD to healthy volunteers of the same age.
This trial tests a personalized exercise program for people with peripheral arterial disease (PAD), a condition that causes leg pain when walking. The goal is to see if a tailored exercise plan can help reduce pain, improve walking distance, and boost quality of life.
This study looks at how diet changes and an exercise program may improve walking and leg symptoms in people with peripheral artery disease (PAD). You may be eligible if you have a history of claudication (leg pain with walking) and tests or treatment history show PAD.
This trial tests whether drinking beetroot juice can improve how well people with peripheral artery disease (PAD) can function and walk. It’s looking at circulation-related measurements in the legs and how you do on walking tests.
Hear when a new Peripheral Arterial Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.